Search results
Results from the WOW.Com Content Network
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [ 2 ] [ 5 ] [ 6 ] [ 7 ] It combines sofosbuvir and velpatasvir .
Velpatasvir reaches highest blood plasma levels three hours after oral intake together with sofosbuvir. Plasma protein binding is over 99.5%. It is slowly metabolised by the liver enzymes CYP2B6, CYP2C8 and CYP3A4.
The U.S. Food and Drug Administration is asking a panel of experts to weigh in on a women's version of the male sexual dysfunction drug Viagra. The FDA is considering Boehringer Ingelheim's drug ...
Newsweek said "[Orgasm Inc.] is a desperately needed antidote to all the hype generated by pharmaceutical companies pursuing their holy grail: a female Viagra." [ 3 ] The Times called it "an extraordinary, revelatory documentary about female desire and the pharmaceutical industry".
The U.S. Food and Drug Administration (FDA) has approved several medications for the treatment of ED, including: Sildenafil (the active ingredient in Viagra or generic versions of Viagra ...
A panel of U.S. Food and Drug Administration experts decided Friday that Boehringer Ingelheim's so-called "female viagra" drug, flibanserin, doesn't provide enough benefit to outweigh the risks.
Women, however, “tend to experience desire in that the liking has to come before the wanting. So, ‘I like this experience. It feels sexy to me, therefore now I want sex.’”
In 2000, Viagra sales accounted for 92% of the global market for prescribed erectile dysfunction pills. [77] By 2007, Viagra's global share had plunged to about 50% [78] due to several factors, including the entry of Cialis and Levitra, along with several counterfeits and clones, and reports of vision loss in people taking PDE5 inhibitors.